About the journal
Frontiers in Pharmacology is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,150 CHF. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Frontiers Media S.A.
- ISSN
- 1663-9812
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,150 CHF
- Articles in DOAJ
- 31507
- Declared review time
- 14 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.frontiersin.org/journals/pharmacology
Index listings
- DOAJ · 2010-12-09
- PUBMED · 2013-09-09
- Indexing
- DOAJ · PUBMED
- APC
- 3,150 CHF
- Declared review time (DOAJ)
- 14 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
31507
Most recent article
last month
Average review time (journal-declared via DOAJ)
14weeks
Works in OpenAlex
31469
Last recorded publication year
2026
h-index
237
i10-index
16627
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-12
- Added to DOAJ
- 2010-12-09
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101548923
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Pharmacological Effects of Natural Compounds
- Pharmacological Effects of Natural Compounds
- Computational Drug Discovery Methods
- Traditional Chinese Medicine Analysis
- Computational Drug Discovery Methods
- Traditional Chinese Medicine Analysis
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
Show all subjects (50)
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Neuroscience and Neuropharmacology Research
- Neuroscience and Neuropharmacology Research
- Tryptophan and brain disorders
- Tryptophan and brain disorders
- Pharmacogenetics and Drug Metabolism
- Neuroinflammation and Neurodegeneration Mechanisms
- Pharmacogenetics and Drug Metabolism
- Neuroinflammation and Neurodegeneration Mechanisms
- Gut microbiota and health
- Natural product bioactivities and synthesis
- Natural product bioactivities and synthesis
- Gut microbiota and health
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Ginseng Biological Effects and Applications
- Ginseng Biological Effects and Applications
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Metabolomics and Mass Spectrometry Studies
- Drug-Induced Hepatotoxicity and Protection
- Metabolomics and Mass Spectrometry Studies
- Cancer-related molecular mechanisms research
- Drug-Induced Hepatotoxicity and Protection
- Cancer-related molecular mechanisms research
- Receptor Mechanisms and Signaling
- Receptor Mechanisms and Signaling
- Cancer Immunotherapy and Biomarkers
- Inflammasome and immune disorders
- Inflammasome and immune disorders
- Pharmacovigilance and Adverse Drug Reactions
- Cancer Immunotherapy and Biomarkers
- Ion channel regulation and function
- Ion channel regulation and function
- MicroRNA in disease regulation
- Pharmacovigilance and Adverse Drug Reactions
- MicroRNA in disease regulation
- Health Systems, Economic Evaluations, Quality of Life
- Cannabis and Cannabinoid Research
- Health Systems, Economic Evaluations, Quality of Life
- Cannabis and Cannabinoid Research
Keywords (DOAJ)
- pharmacology
- pharmaceutics
- ethnopharmacology
- experimental pharmacology
- neuropharmacology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ